BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16520355)

  • 1. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.
    Choi BO; Jang HS; Kang KM; Lee SW; Kang YN; Chai GY; Choi IB
    Jpn J Clin Oncol; 2006 Mar; 36(3):154-8. PubMed ID: 16520355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
    Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
    Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy for large hepatocellular carcinoma.
    Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas.
    Selch MT; Ahn E; Laskari A; Lee SP; Agazaryan N; Solberg TD; Cabatan-Awang C; Frighetto L; Desalles AA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):101-11. PubMed ID: 15093905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
    Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
    Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
    Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam therapy for aged patients with hepatocellular carcinoma.
    Hata M; Tokuuye K; Sugahara S; Tohno E; Nakayama H; Fukumitsu N; Mizumoto M; Abei M; Shoda J; Minami M; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):805-12. PubMed ID: 17524568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
    Kawashima M; Furuse J; Nishio T; Konishi M; Ishii H; Kinoshita T; Nagase M; Nihei K; Ogino T
    J Clin Oncol; 2005 Mar; 23(9):1839-46. PubMed ID: 15774777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation treatment outcomes for unresectable hepatocellular carcinoma.
    Skinner HD; Sharp HJ; Kaseb AO; Javle MM; Vauthey JN; Abdalla EK; Delclos ME; Das P; Crane CH; Krishnan S
    Acta Oncol; 2011 Nov; 50(8):1191-8. PubMed ID: 21793641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
    Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
    Hamamoto Y; Niino K; Ishiyama H; Hosoya T
    Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
    Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
    Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.
    Yang ZX; Wang D; Wang G; Zhang QH; Liu JM; Peng P; Liu XH
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):625-30. PubMed ID: 19882171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
    Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.